Updated August 6, 2026

NovoLog Patient Assistance Program (2026): Eligibility, Application & Income Limits

Evan Brown
Written by Evan Brown
Prescription Savings Researcher
Dr Megan Harris Medically Reviewed by Dr. Megan Harris, MD
Editorial Review: This guide explains how the NovoLog Patient Assistance Program works in 2026 — who qualifies, what documents you need, how the application moves through review, and what to expect once your insulin ships.
Quick Answer

NovoLog (insulin aspart) is available at $0 cost through the Novo Nordisk Patient Assistance Program (PAP) for uninsured or underinsured patients with household income at or below 400% of the federal poverty level (about $62,600 for one person). Unlike Ozempic, NovoLog applicants do not need a Medicaid denial letter. You'll need a completed prescriber section, proof of income, and proof of insurance status. Apply online at NovoCare.com or call 1-866-310-7549 (Mon–Fri, 8am–8pm ET). Approved NovoLog ships free to your home through Neovance Specialty Pharmacy, usually within 5 business days.

Key Takeaways

  • NovoLog is covered under the 2026 PAP for both vial and FlexPen presentations, with no Medicaid denial letter required for uninsured applicants.
  • The income ceiling is 400% of the federal poverty level, roughly $62,600 for a single-person household, scaling up with household size.
  • Both the patient and a licensed prescriber must complete separate sections of the same application.
  • Approved insulin ships directly to your home through Neovance Specialty Pharmacy, not to a pharmacy counter.
  • Enrollment lasts about 12 months. You must reapply with updated income and insurance documentation to keep your supply uninterrupted.

NovoLog is one of the most widely prescribed rapid-acting insulins in the country, and it's also one of the most expensive to buy without coverage. A single box of pens can run several hundred dollars, and many patients need two or three boxes a month to stay on dose. For anyone without adequate prescription drug coverage, that math doesn't work for long.

The NovoLog Patient Assistance Program exists to close that gap. It isn't a coupon or a discount card — it's a full replacement of the out-of-pocket cost for patients who qualify, funded directly by Novo Nordisk and administered through its NovoCare support division. The tradeoff is paperwork: a two-part application, income verification, and a prescriber who has to sign off on medical necessity.

This guide walks through exactly what NovoLog's PAP requires in 2026, how it differs from the rules for GLP-1 medications like Ozempic, and what to do at each stage from application to delivery to renewal.

What Is NovoLog and Why the PAP Matters

NovoLog (insulin aspart) is a rapid-acting insulin used to control blood sugar spikes around mealtimes, most often alongside a longer-acting basal insulin such as Tresiba. It's available as a vial for syringe use, a prefilled FlexPen, and a PenFill cartridge for reusable pen devices.

Because it's a biologic and not a small-molecule generic drug, there's no low-cost generic version on the market the way there is for many oral medications. Patients who lose insurance, switch to a high-deductible plan, or simply never had drug coverage in the first place are often left facing full retail pricing with no easy substitute.

Why this matters: Rationing rapid-acting insulin — skipping doses or stretching supply — is medically dangerous. The PAP is built specifically to prevent patients from having to make that choice.

What Is the Novo Nordisk Patient Assistance Program (NovoCare)?

NovoCare is Novo Nordisk's patient support division. It runs three separate but related programs, and understanding which one applies to your situation will save you time.

NovoCare programs at a glance
Program Who It's For What It Does
Patient Assistance Program (PAP) Uninsured/underinsured, income-eligible patients Provides NovoLog at $0 cost
NovoLog Savings Card Patients with eligible commercial insurance Reduces monthly copay
Insurance Navigation Anyone needing help with coverage or appeals Assists with prior authorizations and formulary appeals

General PAP support: 1-866-310-7549 (Mon–Fri, 8am–8pm ET). Savings card support: 1-844-465-4262. Delivery questions go to Neovance Specialty Pharmacy at 1-800-488-5908.

NovoLog PAP Eligibility at a Glance

Broadly, you're a strong candidate for the NovoLog PAP if the following apply:

  • You are a U.S. resident currently prescribed NovoLog (or a comparable insulin aspart product).
  • You have no prescription drug coverage, or your current plan doesn't adequately cover NovoLog.
  • Your household income falls at or below 400% of the federal poverty level for your household size.
  • You have a licensed prescriber willing to complete and sign the prescriber section of the application.

You're less likely to qualify if:

  • You have commercial insurance that already covers NovoLog at a reasonable copay.
  • Your household income is above the 400% FPL threshold for your household size.
  • You have Medicaid, which typically already covers insulin.
  • Your application is missing the prescriber signature or income documentation.

Income Limits for NovoLog Assistance (2026)

NovoLog falls under the PAP's standard 400% federal poverty level threshold — the same ceiling used for other Novo Nordisk insulins and diabetes medications, as opposed to the stricter 200% FPL limit that now applies to Ozempic.

2026 NovoLog PAP income limits by household size
Household Size Annual Income Limit (400% FPL)
1 Person~$62,600
2 People~$84,600
3 People~$106,600
4 People~$128,600
5 People~$150,600
6 People~$172,600
7 People~$194,600
8 People~$216,600

Alaska and Hawaii use higher thresholds. For households larger than 8, add roughly $22,000 per additional person to the limit above.

NovoLog vs Other Insulins on the 2026 PAP

NovoLog isn't the only Novo Nordisk insulin on the PAP formulary. Here's how it compares to the other most commonly requested products.

2026 PAP insulin formulary comparison
Medication Type Income Limit Notes
NovoLog Rapid-acting (insulin aspart) 400% FPL Vial and FlexPen covered; no Medicaid denial letter required
Fiasp Faster-acting insulin aspart 400% FPL Prescriber must name "Fiasp" specifically, not generic insulin aspart
Tresiba Basal (long-acting) 400% FPL Primary alternative for patients previously on discontinued Levemir
Novolin (N/R/70-30) Human insulin 400% FPL Often fastest to approve due to simpler documentation
Ozempic GLP-1 (Type 2 diabetes) 200% FPL, uninsured only Stricter 2026 rules; Medicare excluded; Medicaid denial required

If your prescriber has you on both a rapid-acting and a basal insulin, you can apply for both on the same application — just make sure your prescriber lists the exact brand name and dose for each.

NovoLog Savings Card vs Patient Assistance Program

These two programs solve different problems, and mixing them up is one of the most common reasons applications get sent back.

NovoLog PAP vs. Savings Card (2026)
Feature Patient Assistance Program NovoLog Savings Card
Best for Uninsured or underinsured patients Commercially insured patients
Cost $0 As low as $35/month
Income limit 400% FPL None
Medicare/Medicaid eligible? Case-by-case (Medicare); usually no (Medicaid) No — federal law prohibits
Application complexity Two-part form, income proof required Simple enrollment, no income proof
Phone 1-866-310-7549 1-844-465-4262

Bottom line: If you have commercial insurance that already covers NovoLog, the savings card is faster and skips income verification entirely. If you're uninsured and under the income limit, the PAP is the better fit because it eliminates the cost completely rather than just reducing it.

Insurance Status Requirements

The program looks past whether you technically hold insurance and focuses on whether that coverage is adequate for the medication you need.

Insurance Situation Typically Eligible?
No health insurance at all Usually Yes
Insurance with no prescription drug benefit Usually Yes
Medicare Part D with NovoLog excluded or unaffordable Case-by-Case
Commercial insurance that already covers NovoLog Usually No — savings card instead
Medicaid Usually No — Medicaid typically covers insulin

If you're on Medicare and unsure whether your Part D plan counts as adequate coverage, our Medicare and Patient Assistance Programs guide walks through how that determination gets made, and our Extra Help (LIS) explainer covers the low-income subsidy denial letter some applicants need.

Required Documents

Missing paperwork is the single biggest cause of processing delays. Here's exactly what you need to gather before you start.

Document Who Needs It Purpose
Completed patient section Everyone Identity, household size, income, insurance status
Completed prescriber section Everyone Confirms diagnosis, exact medication, and dose
Proof of income Everyone Recent tax return, pay stubs, or Social Security statement
Proof of inadequate insurance Insured applicants Formulary exclusion letter or explanation of benefits showing high cost-sharing
Medicare Extra Help (LIS) denial Medicare patients below 150% FPL Proves you were denied the Low Income Subsidy
Valid prescription Everyone Confirms the specific NovoLog product and dose
Government-issued photo ID Maine & Minnesota residents State-specific requirement

Note: NovoLog applicants do not need a Medicaid denial letter unless your income also puts you near the Medicaid eligibility threshold in your state. This is a key difference from the Ozempic PAP process.

How to Apply for NovoLog Patient Assistance, Step by Step

1

Start the application online or by phone

Go to the NovoCare PAP portal or call 1-866-310-7549 to request a form. Online applications are processed faster and can be completed on a phone or computer in one sitting.

2

Fill in the patient section

Enter your name, address, household size, income, and current insurance status exactly as it appears on your supporting documents. Mismatches between the form and your paperwork are a common cause of delay.

3

Get the prescriber section completed

Your provider confirms your diagnosis, specifies "NovoLog" (or Fiasp, if that's what's prescribed) along with the exact dose, and signs the form. This section cannot be left blank or filled in by the patient.

4

Attach income and insurance documentation

Include a recent tax return or pay stubs, plus any documentation showing your insurance doesn't adequately cover NovoLog — or proof you have no coverage at all.

5

Submit the completed application

Submit online for the fastest turnaround, or fax the completed packet to 1-866-364-6633.

6

Wait for a decision and set up delivery

You'll get written notice of approval or denial. If approved, Neovance Specialty Pharmacy will call to schedule your first shipment.

Ready to apply? Start directly with NovoCare.

Call 1-866-310-7549 (Monday–Friday, 8am–8pm ET) or complete the application online at the official NovoCare patient support portal.

Go to NovoCare → See Required Documents

Decision Tree: Is the PAP Right for You?

Step 1: Do you have commercial insurance that already covers NovoLog?

✔ Yes → Look at the NovoLog Savings Card instead.

✖ No → Continue to Step 2.


Step 2: Is your household income at or below 400% FPL for your household size?

✔ Yes → Continue to Step 3.

✖ No → The PAP likely isn't a fit; consider a disease-specific foundation or state pharmaceutical assistance program.


Step 3: Do you have a valid prescription and a provider willing to sign the prescriber section?

✔ Yes → You're a strong PAP candidate — start the application.

✖ No → Schedule a visit first. The prescriber section is required before submission.

How Long Approval Takes

Situation Typical Timeframe
Complete online application, all documents attached 1–2 business days
Fax or mail submission 7–10 business days
Missing documents or incomplete fields Delayed until resubmitted
Renewal application 1–3 weeks (submit 30 days before expiration)

To check status, call 1-866-310-7549 with your confirmation number ready.

How NovoLog Is Delivered

Step What Happens
Approval You and your prescriber receive written notification
Pharmacy call Neovance Specialty Pharmacy calls at 1-800-488-5908 to schedule delivery
Shipment NovoLog ships within 5 business days to your home address
Refills Neovance contacts you when a refill is due; update address by calling 1-866-310-7549

Important: Insulin requires temperature-controlled shipping. Someone needs to be available to receive the package promptly and refrigerate unopened pens or vials right away.

Renewing Your Enrollment

Enrollment typically runs about 12 months. Since NovoLog is a maintenance medication most patients need indefinitely, missing your renewal window can create a dangerous gap in supply.

  • Start renewal before your current enrollment period ends.
  • Submit updated income documentation, even if your income hasn't changed.
  • Confirm your prescriber's office still has your case on file, since renewal also requires a new signature.
  • Report any change in insurance status right away — gaining adequate coverage can end PAP eligibility mid-cycle.

Pros and Cons of Using the PAP for NovoLog

Pros

  • Medication cost drops to $0 for approved patients
  • No Medicaid denial letter required for uninsured applicants
  • Home delivery with free shipping
  • Covers both vial and FlexPen presentations
  • Fast turnaround on complete online applications

Cons

  • Requires a prescriber signature you have to coordinate
  • Annual reapplication with fresh documentation
  • Income limit excludes many middle-income households
  • Cannot ship to a local retail pharmacy for pickup
  • Processing delays if any single document is missing

Common Mistakes That Delay NovoLog Applications

  • Prescriber section left blank or unsigned
  • Income documentation that doesn't match the household size listed
  • Applying for "insulin aspart" generically instead of naming NovoLog or Fiasp specifically
  • Outdated income documents older than the program's accepted window
  • Renewal submitted after the enrollment period already lapsed
  • Contact information that doesn't match between patient and prescriber sections

Nearly all of these are simple paperwork mismatches. Reviewing every field against your supporting documents before you submit avoids the most common holdups.

Real Patient Scenarios

Scenario: Recently laid off, COBRA too expensive

A single applicant lost employer coverage and can't afford COBRA. Household income from unemployment benefits falls well under the $62,600 single-person limit. With a prescriber's signature and a recent pay stub showing the income drop, this applicant is a straightforward approval.

Scenario: Family of four, high-deductible plan

A family of four has commercial insurance, but their plan has a $7,000 deductible and NovoLog isn't affordable until it's met. Because they technically have coverage, they'll likely need an explanation of benefits showing the out-of-pocket cost before PAP will consider them — otherwise the savings card may be the quicker route.

Scenario: Medicare patient with a formulary gap

A Medicare Part D enrollee finds NovoLog isn't on their plan's formulary and the off-formulary cost is unaffordable. With a formulary exclusion letter from their Part D plan attached to the application, this patient can be evaluated case-by-case for PAP eligibility.

What to Do If You're Denied

Reason for Denial Next Step
Income slightly above threshold Explore nonprofit foundation grants or state pharmaceutical assistance programs
Missing documentation Resubmit with all required documents attached
Existing adequate coverage Use the NovoLog Savings Card instead
Incomplete prescriber section Return to your prescriber's office to complete the form

Independent disease-specific foundations, state pharmaceutical assistance programs, and hospital or clinic charity care programs are all worth checking if you don't qualify for PAP. Our insulin savings programs roundup and GoodRx vs. Inside Rx comparison cover cash-price alternatives that don't require an income test.

Frequently Asked Questions

Yes, for eligible patients. NovoLog is covered under the 2026 PAP at no cost to patients whose household income is at or below 400% of the federal poverty level and who lack adequate prescription drug coverage.

No. Unlike Ozempic, uninsured patients applying for NovoLog are not required to submit a Medicaid denial letter under the 2026 rules. You'll still need to document your income and lack of adequate insurance coverage.

Medicare patients are reviewed case by case. If your Part D plan doesn't cover NovoLog, places it on a high cost-sharing tier, or you were denied Extra Help (Low Income Subsidy), you may still qualify with the right denial documentation.

Both are insulin aspart products from Novo Nordisk, and both are covered under the 2026 PAP at 400% FPL. NovoLog is the original rapid-acting formulation; Fiasp is a faster-acting formulation. Your prescriber must specify the exact product name on the application, since they aren't interchangeable on the form.

Complete online applications with all documents attached are typically decided in 1 to 2 business days. Fax or mail submissions take about 7 to 10 business days. Missing documents delay review until resubmitted.

Approved NovoLog ships directly to your home from Neovance Specialty Pharmacy, generally within 5 business days of approval. It cannot be shipped to a retail pharmacy counter.

Yes. Enrollment typically lasts about 12 months. You need to submit updated income and insurance documentation before your enrollment period ends to avoid a gap in supply.

You likely won't qualify for this specific program, but disease-specific foundations, state pharmaceutical assistance programs, and hospital charity care programs may still be able to help. A NovoLog savings card is also worth checking if you have commercial insurance.


How We Researched This Guide

This guide was prepared by the Refill Relay Editorial Team using publicly available manufacturer patient assistance program documentation, federal poverty level guidelines, and standard patient assistance program application and renewal practices used across the pharmaceutical industry.

Every article undergoes editorial review for accuracy, readability, and consistency before publication. Our goal is to explain patient assistance programs in clear language so patients and caregivers can access affordable medication with less friction.


References

  1. Novo Nordisk. NovoCare Patient Assistance Program Overview and Application Materials.
  2. Novo Nordisk US. Product and Patient Support Information.
  3. U.S. Department of Health and Human Services. Federal Poverty Level Guidelines.
  4. Medicare.gov. Part D Prescription Drug Coverage.
  5. Centers for Medicare & Medicaid Services. Medicare Part D Coverage Guidance.
  6. U.S. Food & Drug Administration. Drug Product Information.
  7. NeedyMeds. Patient Assistance Program Directory.
  8. National Council on Aging. BenefitsCheckUp Assistance Screening Tool.

About Refill Relay

Refill Relay publishes evidence-based educational resources that help patients understand prescription insurance, patient assistance programs, pharmacy benefits and medication access. Our editorial team combines manufacturer program research with practical guidance to make complex healthcare topics easier to navigate.

Editorial Standards

  • Evidence-based program research
  • Editorial review before publication
  • Regular updates when program eligibility rules change
  • Clear distinction between educational content and medical or financial advice

Related Resources

Editorial Policy: Refill Relay content is researched using publicly available manufacturer patient assistance program materials, federal poverty guidelines, and standard industry application practices. Every article is reviewed for clarity, accuracy and usefulness before publication.

Evan Brown
About the Author
Evan Brown — Prescription Savings Researcher

Evan Brown is a prescription savings researcher who specializes in translating complex healthcare policy — including manufacturer patient assistance programs — into clear, actionable guidance for patients.

View Full Profile →
Dr. Megan Harris, MD
Medical Review
Dr. Megan Harris, MD — Board-Certified Internal Medicine

Dr. Megan Harris, MD reviews health content for accuracy, checking eligibility criteria and program documentation practices against current manufacturer and CMS guidance.

View Full Profile →

Contact Refill Relay